Graphene news. MUNASET will develop a rapid, highly sensitive and easy-to-use graphene-based biosensor platform to address therapy response prediction and allow faster and more precise treatment identification, improve therapy outcomes and reduce hospitalisation time. MUNASET will also help secure Europe’s industrial leadership over the entire value chain of novel graphene-based bio-analytical tools. The project, funded by the European Commission’s Horizon Europe programme, is part of the Graphene Flagship initiative which works to advance technologies that rely on graphene and other 2D materials.